PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES. (23rd June 2022) - Zeidan, A.; Divino, V.; DeKoven, M.; Shah, D.; Wang, E.; Bey, D.; Salimi, T.; Epstein, R.